Cargando…

Heterodimeric IL-15 in Cancer Immunotherapy

SIMPLE SUMMARY: The rapidly expanding field of cancer immunotherapy uses diverse technologies, including cytokines, T cells, and antibody administration, with the aim to induce effective immune responses leading to tumor control. Interleukin-15 (IL-15), a cytokine discovered in 1994, supports the ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bergamaschi, Cristina, Stravokefalou, Vasiliki, Stellas, Dimitris, Karaliota, Sevasti, Felber, Barbara K., Pavlakis, George N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922495/ https://www.ncbi.nlm.nih.gov/pubmed/33671252 http://dx.doi.org/10.3390/cancers13040837

Ejemplares similares

Heterodimeric IL-15 (hetIL-15) reduces circulating tumor cells and metastasis formation improving chemotherapy and surgery in 4T1 mouse model of TNBC
por: Stravokefalou, Vasiliki, et al.
Publicado: (2023)

Scalable, cGMP-compatible purification of extracellular vesicles carrying bioactive human heterodimeric IL-15/lactadherin complexes
por: Watson, Dionysios C., et al.
Publicado: (2018)

Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10
por: Bergamaschi, Cristina, et al.
Publicado: (2020)

Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients
por: Bergamaschi, Cristina, et al.
Publicado: (2021)

Heterodimeric IL-15 regulates the differentiation and survival of different populations of memory T cells and the balance of effector and regulatory cells
por: Pavlakis, George N, et al.
Publicado: (2013)

Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes
por: Watson, Dionysios C., et al.
Publicado: (2018)

Intramuscular delivery of heterodimeric IL-15 DNA in macaques produces systemic levels of bioactive cytokine inducing proliferation of NK and T cells
por: Bergamaschi, C, et al.
Publicado: (2015)

Correction: Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes
por: Watson, Dionysios C., et al.
Publicado: (2018)

IL-15/IL-15Rα Heterodimeric Complex as Cancer Immunotherapy in Murine Breast Cancer Models
por: Guo, Siqi, et al.
Publicado: (2021)

Optimized administration of hetIL-15 expands lymphocytes and minimizes toxicity in rhesus macaques
por: Bergamaschi, Cristina, et al.
Publicado: (2018)

Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors
por: Conlon, Kevin, et al.
Publicado: (2021)

SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors
por: Terpos, Evangelos, et al.
Publicado: (2021)

HIV DNA Vaccine: Stepwise Improvements Make a Difference
por: Felber, Barbara K., et al.
Publicado: (2014)

Exploiting an Interleukin-15 Heterodimeric Agonist (N803) for Effective Immunotherapy of Solid Malignancies
por: Lui, Grace, et al.
Publicado: (2023)

Delineating the SARS-CoV-2 Induced Interplay between the Host Immune System and the DNA Damage Response Network
por: Papanikolaou, Christina, et al.
Publicado: (2022)

Step-dose IL-7 treatment promotes systemic expansion of T cells and alters immune cell landscape in blood and lymph nodes
por: Pandit, Hrishikesh, et al.
Publicado: (2023)

Genome-Wide Analysis of lncRNA-mRNA Co-Expression Networks in CD133+/CD44+ Stem-like PDAC Cells
por: Eptaminitaki, Giasemi C., et al.
Publicado: (2023)

Kinetics of Nucleocapsid, Spike and Neutralizing Antibodies, and Viral Load in Patients with Severe COVID-19 Treated with Convalescent Plasma
por: Thomopoulos, Thomas P., et al.
Publicado: (2021)

Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy
por: Eptaminitaki, Giasemi C., et al.
Publicado: (2021)

Nuclear export factor RBM15 facilitates the access of DBP5 to mRNA
por: Zolotukhin, Andrei S., et al.
Publicado: (2009)

A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis
por: Pappa, Vasiliki, et al.
Publicado: (2021)

Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy
por: Yang, Ying, et al.
Publicado: (2020)

A GATA2-CDC6 axis modulates androgen receptor blockade-induced senescence in prostate cancer
por: Mourkioti, Ioanna, et al.
Publicado: (2023)

The p40 Subunit of Interleukin (IL)-12 Promotes Stabilization and Export of the p35 Subunit: IMPLICATIONS FOR IMPROVED IL-12 CYTOKINE PRODUCTION
por: Jalah, Rashmi, et al.
Publicado: (2013)

IL-15 in the Combination Immunotherapy of Cancer
por: Waldmann, Thomas A., et al.
Publicado: (2020)

Preservation of a subset of SIV-specific central memory CD4+ T cells correlates with control of viremia in SIVmac251 infected macaques
por: Felber, Barbara K, et al.
Publicado: (2006)

Sub-1.5 nm-gapped heterodimeric plasmonic nanomolecules
por: Song, Xiaojun, et al.
Publicado: (2022)

The RNA-binding Motif Protein 15B (RBM15B/OTT3) Acts as Cofactor of the Nuclear Export Receptor NXF1
por: Uranishi, Hiroaki, et al.
Publicado: (2009)

A novel multimeric IL15/IL15Rα-Fc complex to enhance cancer immunotherapy
por: Xu, Hong, et al.
Publicado: (2021)

Expanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine Family
por: Hasegawa, Hideaki, et al.
Publicado: (2016)

Functional Consequences of GPCR Heterodimerization: GPCRs as Allosteric Modulators
por: Haack, Karla K.V., et al.
Publicado: (2011)

Emerging Roles of TWIK-1 Heterodimerization in the Brain
por: Cho, Chang-Hoon, et al.
Publicado: (2017)

The contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for the immunotherapy of rheumatological diseases
por: Waldmann, Thomas
Publicado: (2002)

Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors
por: Somvanshi, Rishi K., et al.
Publicado: (2012)

Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model
por: Berger, Alexandra, et al.
Publicado: (2019)

Heterodimeric Plasmonic Nanogaps for Biosensing
por: Chatterjee, Sharmistha, et al.
Publicado: (2018)

Targeted cancer immunotherapy: Mimicking physiological trans-presentation of IL-15
por: Müller, Dafne
Publicado: (2012)

A very long-acting IL-15: implications for the immunotherapy of cancer
por: Hangasky, John A, et al.
Publicado: (2022)

HLJ1 amplifies endotoxin-induced sepsis severity by promoting IL-12 heterodimerization in macrophages
por: Luo, Wei-Jia, et al.
Publicado: (2022)

Co-expression IL-15 receptor alpha with IL-15 reduces toxicity via limiting IL-15 systemic exposure during CAR-T immunotherapy
por: Zhang, Ying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u8dqdjqf52vcstgndanqvtqsm0